Korean medication algorithm for depressive disorder: comparisons with other treatment guidelines

Area of Science:

• Psychiatry
• Clinical Pharmacology
• Evidence-Based Medicine

Background:

• The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) provides treatment recommendations.
• Current global treatment guidelines for depressive disorder are evolving.
• Comparing national algorithms with international standards is crucial for clinical practice.

Purpose of the Study:

• To compare the KMAP-DD 2012 recommendations with recent global treatment guidelines for depressive disorder.
• To identify similarities and discrepancies in depression treatment strategies.
• To assess the alignment of KMAP-DD 2012 with current international best practices.

Main Methods:

• A systematic review of five recently published global treatment guidelines for depressive disorder.
• Comparative analysis of treatment recommendations between KMAP-DD 2012 and selected international guidelines.
• Evaluation of recommendations for initial treatment, nonresponse, maintenance therapy, subtypes, and special populations.

Main Results:

• Initial treatment recommendations showed broad agreement across guidelines.
• Significant variations were observed in second-step treatments for nonresponse or incomplete response.
• Differences were noted in maintenance therapy, including medication dosage and duration.
• Discrepancies existed in recommendations for specific depressive disorder subtypes.
• Overall recommendations for special populations were largely consistent.

Conclusions:

• The KMAP-DD 2012 generally aligns with current global treatment guidelines for depression.
• The algorithm reflects recent research and prescription patterns.
• Further research is needed to address identified discrepancies in treatment steps and subtypes.